Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Improving test properties for neonatal cystic fibrosis screening in the Netherlands before the nationwide start by May 1st 2011.

Journal of inherited metabolic disease - 1 Jul 2012

Cornel Martina C, Gille Johan J P, Loeber J Gerard, Vernooij-van Langen Annette M M, Dankert-Roelse Jeannette, Bolhuis Piet A

Abstract excerpt

When new technical possibilities arise in health care, often attunement is needed between different actors from the perspectives of research, health care providers, patients, ethics and policy. For cystic fibrosis (CF) such a process of attunement in the Netherlands started in a committee of the Health Council on neonatal screening in 2005. In the balancing of pros and cons according to Wilson and Jungner...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cystic Fibrosis
Share to Cystic Fibrosis Transmembrane Conductance Regulator

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mass Screening

Share to Neonatal Screening

Share to Netherlands

Share to Parents

Share to Pilot Projects

Source

Open in PubMed Open full text

Identifiers

PMID: 22302635
DOI: 10.1007/s10545-012-9452-7
PMCID: PMC3388251

Genes

CFTR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Improving test properties for neonatal cystic fibrosis screening in the Netherlands before the nationwide start by May 1st 2011.PMID 22302635Read ↗

Neonatal screening for cystic fibrosis: France rises to the challenge.Semantic proximity Read ↗

[Newborn screening for cystic fibrosis in France].Semantic proximity Read ↗

[The example of cystic fibrosis to highlight the complexity of genetic screening].Semantic proximity Read ↗

Four-year evaluation of neonatal cystic fibrosis screening in Southern Belgium.Semantic proximity Read ↗

Neonatal screening of cystic fibrosis: diagnostic problems with CFTR mild mutations.Semantic proximity Read ↗

[Neonatal screening of cystic fibrosis: diagnostic and ethical problems with mild mutations].Semantic proximity Read ↗

Implementation of newborn screening for cystic fibrosis in Norway. Results from the first three years.Semantic proximity Read ↗

False-positive results in neonatal screening for cystic fibrosis based on a three-stage protocol (IRT/DNA/IRT): Should we adjust IRT cut-off to ethnic origin?Semantic proximity Read ↗

A Low-Cost and Simple Genetic Screening for Cystic Fibrosis Provided by the Brazilian Public Health System.Semantic proximity Read ↗

Differences in clinical condition and genotype at time of diagnosis of cystic fibrosis by newborn screening or by symptoms.Semantic proximity Read ↗

Benchmarks for cystic fibrosis carrier screening: a European consensus document.Semantic proximity Read ↗

Diagnosing cystic fibrosis in newborn screening in Poland - 15 years of experience.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.